Somewhat Positive News Coverage Somewhat Unlikely to Impact Innospec (IOSP) Stock Price
Media coverage about Innospec (NASDAQ:IOSP) has trended somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Innospec earned a news impact score of 0.20 on Accern’s scale. Accern also assigned press coverage about the specialty chemicals company an impact score of 47.1399961183604 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
These are some of the news stories that may have impacted Accern’s scoring:
- Arizona State Retirement System Has $2.86 Million Position in Innospec Inc. (IOSP) (americanbankingnews.com)
- Innospec (IOSP) Upgraded by ValuEngine to Buy (americanbankingnews.com)
- Innospec (IOSP) versus KMG Chemicals (KMG) Critical Comparison (americanbankingnews.com)
- Innospec Inc. (IOSP) Position Lifted by Lazard Asset Management LLC (americanbankingnews.com)
- Innospec Inc. (IOSP) Shares Bought by Schwab Charles Investment Management Inc. (americanbankingnews.com)
Innospec (NASDAQ:IOSP) opened at $64.10 on Monday. The stock has a market capitalization of $1,560.85, a PE ratio of 25.54 and a beta of 1.13. Innospec has a 1-year low of $54.10 and a 1-year high of $74.30. The company has a quick ratio of 1.34, a current ratio of 2.15 and a debt-to-equity ratio of 0.26.
Several brokerages have recently commented on IOSP. ValuEngine upgraded Innospec from a “hold” rating to a “buy” rating in a report on Thursday. Zacks Investment Research cut Innospec from a “hold” rating to a “strong sell” rating in a report on Friday, February 23rd. KeyCorp restated an “overweight” rating on shares of Innospec in a report on Thursday, November 9th. BidaskClub cut Innospec from a “hold” rating to a “sell” rating in a report on Thursday, January 25th. Finally, Monness Crespi & Hardt cut Innospec from a “buy” rating to a “neutral” rating in a report on Thursday, November 9th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $70.50.
In related news, VP Catherine Hessner sold 1,382 shares of the firm’s stock in a transaction dated Monday, February 26th. The stock was sold at an average price of $68.24, for a total value of $94,307.68. Following the transaction, the vice president now owns 27,518 shares in the company, valued at $1,877,828.32. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Philip John Boon sold 501 shares of the firm’s stock in a transaction dated Wednesday, February 21st. The shares were sold at an average price of $67.04, for a total value of $33,587.04. Following the completion of the transaction, the vice president now owns 35,439 shares in the company, valued at approximately $2,375,830.56. The disclosure for this sale can be found here. In the last quarter, insiders sold 7,286 shares of company stock worth $498,239. 2.02% of the stock is owned by company insiders.
WARNING: This report was first posted by Watch List News and is owned by of Watch List News. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at https://www.watchlistnews.com/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-innospec-iosp-stock-price/1909347.html.
Innospec Inc is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives.
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.